Discover 2,717 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,717
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
for
Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma,
Location: Toronto, Dallas TX, San Antonio TX
Sponsor: Auricula Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07148128
Phase1, Phase2, Recruiting
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
for
Aortic Stenosis
Location: Boston MA, New York NY, Albany NY, Summit NJ, Montreal,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT05646381
Phase2, Recruiting
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
for
Neoplasms
Location: Toronto, Montreal, Philadelphia PA, San Antonio TX
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07438782
Phase1, Recruiting
Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium
for
Postpartum Hemorrhage
Location: Toronto
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Sex: Female
Age: 18 - 45
Code: NCT06285409
Recruiting
Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
for
Postpartum Hemorrhage
Location: Toronto
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Sex: Female
Age: 19 - 45
Code: NCT06285396
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: St. John's, Halifax, Trois-Rivieres, Montreal, Ajax,
Sponsor: Avalyn Pharma Inc.
Sex: All
Age: 40+
Code: NCT07194382
Phase2, Recruiting
Probiotic Research On Safety, Palatability, Efficacy and Receptivity
for
Probiotic Intervention
Location: Ottawa
Sponsor: Carleton University
Sex: Female
Age: 18 - 40
Code: NCT07512557
Recruiting
Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study
for
Hypotension
Location: Toronto
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Sex: Female
Age: 19 - 40
Code: NCT04053478
Recruiting
Fampridine-SR and Optic Neuritis Recovery
for
Optic Neuritis
Location: London
Sponsor: Courtney Casserly
Sex: All
Age: 18 - 64
Code: NCT04148781
Early_phase1, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
for
Breast Neoplasms
Location: Boston MA, Sherbrooke, Westbury NY, White Plains NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06926868
Phase2, Phase3, Recruiting
The Feasibility of Implementing Syphilis Point-of-care Testing Into a Prenatal Clinic for People Facing Barriers to Care
for
Syphilis
Location: Hamilton
Sponsor: McMaster University
Sex: All
Age: 13 - 49
Code: NCT06829602
Recruiting
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
for
Prostate Cancer
Location: Hamilton
Sponsor: Hamilton Health Sciences Corporation
Sex: Male
Age: 18+
Code: NCT06908694
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
for
Invasive Mold Infections
Location: New York NY, Philadelphia PA, Baltimore MD, Ottawa,
Sponsor: Basilea Pharmaceutica
Sex: All
Age: 18+
Code: NCT06925321
Phase3, Recruiting
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
for
Early Alzheimer's Disease
Location: Newton MA, New Haven CT, Queens NY, Toms River NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 50 - 70+
Code: NCT07033494
Phase2, Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
for
Psychosis Associated With Alzheimer's Disease
Location: Levis, West Long Branch NJ, Boca Raton FL,
Sponsor: MapLight Therapeutics
Sex: All
Age: 55 - 70+
Code: NCT06887192
Phase2, Recruiting
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
for
Palmoplantar Pustulosis
Location: Fredericton, Elmhurst NY, Philadelphia PA, Hamilton,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07013201
Phase2, Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
for
Follicular Lymphoma
Location: Towson MD, Fredericksburg VA, Roanoke VA, Toronto,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06911502
Phase3, Recruiting
Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure